Developing neoantigen cancer vaccines: where are we now?

Markosyan N, Vonderheide RH

Open source

DOI: 10.1038/s41467-026-77532-x
Published: 2026 Sep 10
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-77532-x,
  title = {Developing neoantigen cancer vaccines: where are we now?},
  author = {Markosyan N and Vonderheide RH},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-77532-x},
  url = {https://doi.org/10.1038/s41467-026-77532-x}
}

RIS

TY  - JOUR
TI  - Developing neoantigen cancer vaccines: where are we now?
AU  - Markosyan N
AU  - Vonderheide RH
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-77532-x
UR  - https://doi.org/10.1038/s41467-026-77532-x
ER  -

APA

N, M., & RH, V. (2026). Developing neoantigen cancer vaccines: where are we now?. Nature communications. https://doi.org/10.1038/s41467-026-77532-x

Source records

pubmed · retrieved 2026-09-26T06:08:56.996Z
europe-pmc · retrieved 2026-09-26T06:08:57.009Z
doaj · retrieved 2026-09-26T06:08:56.983Z